The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostic relevance of CD4+ T-cells in the microenvironment of newly diagnosed follicular lymphoma (FL) patients is independent of the tumor gene expression profile.
 
Patrizia Mondello
No Relationships to Disclose
 
Angelo Fama
No Relationships to Disclose
 
Melissa C. Larson
No Relationships to Disclose
 
Andew L. Feldman
Research Funding - Seagen (Inst)
Patents, Royalties, Other Intellectual Property - ALF is an inventor of technology for which Mayo Clinic holds an unlicensed patent or has submitted a patent application. (Inst)
 
Zhi-Zhang J Yang
No Relationships to Disclose
 
Jose Caetano Villasboas
Consulting or Advisory Role - Kite/Gilead (Inst)
 
Sarah Huet
No Relationships to Disclose
 
Bruno Tesson
No Relationships to Disclose
 
Susan L. Slager
No Relationships to Disclose
 
Brian K. Link
Consulting or Advisory Role - Abbvie; Genentech/Roche; Karyopharm Therapeutics
Research Funding - Pharmacyclics/Janssen (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Sergei Syrbu
No Relationships to Disclose
 
Anne Novak
No Relationships to Disclose
 
Thomas Matthew Habermann
Consulting or Advisory Role - Celgene; Kite/Gilead
 
Thomas E. Witzig
Consulting or Advisory Role - Abbvie/Genentech (Inst); Celgene (Inst); Cellectar; Epizyme; Immune Design; Incyte (Inst); Karyopharm Therapeutics; MorphoSys (Inst); Portola Pharmaceuticals; Seagen (Inst); Tessa Therapeutics
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Kura Oncology (Inst)
 
Grzegorz S. Nowakowski
Consulting or Advisory Role - Celgene (Inst); Genentech (Inst); MorphoSys (Inst)
Research Funding - Celgene (Inst); MorphoSys (Inst); NanoString Technologies (Inst)
 
Gilles A. Salles
Honoraria - Abbvie; Amgen; Autolus; Celgene; Gilead Sciences; Janssen; Merck; MorphoSys; Novartis; Roche/Genentech; SERVIER; Takeda
Consulting or Advisory Role - Acerta Pharma; Celgene; Epizyme; Gilead Sciences; Janssen; Kite, a Gilead company; Merck; morphosys; Novartis; Pfizer; Roche/Genentech; SERVIER
 
James Robert Cerhan
Consulting or Advisory Role - Janssen; Janssen
Research Funding - Celgene; NanoString Technologies
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Affimed Therapeutics (Inst); AI Therapeutics (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst); Trillium Therapeutics (Inst)